A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
Lampertico, P
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. [electronic resource] - Hepatology (Baltimore, Md.) Dec 1997 - 1621-5 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0270-9139
10.1002/hep.510260634 doi
Adult
Alanine Transaminase--blood
Biopsy
DNA, Viral--blood
Female
Follow-Up Studies
Hepatitis B Antibodies--analysis
Hepatitis B Surface Antigens--blood
Hepatitis B e Antigens--blood
Hepatitis B virus--genetics
Hepatitis B, Chronic--blood
Humans
Interferon alpha-2
Interferon-alpha--adverse effects
Liver--pathology
Male
Middle Aged
Prospective Studies
Recombinant Proteins
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. [electronic resource] - Hepatology (Baltimore, Md.) Dec 1997 - 1621-5 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0270-9139
10.1002/hep.510260634 doi
Adult
Alanine Transaminase--blood
Biopsy
DNA, Viral--blood
Female
Follow-Up Studies
Hepatitis B Antibodies--analysis
Hepatitis B Surface Antigens--blood
Hepatitis B e Antigens--blood
Hepatitis B virus--genetics
Hepatitis B, Chronic--blood
Humans
Interferon alpha-2
Interferon-alpha--adverse effects
Liver--pathology
Male
Middle Aged
Prospective Studies
Recombinant Proteins